United Therapeutics continues to underperform Gilead by 18.0% in the past month

Press/Media

Period24 Mar 2025

Media coverage

6

Media coverage

  • TitleUnited Therapeutics continues to underperform Gilead by 18.0% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date24/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to underperform Alnylam Pharmaceuticals by 30.9% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date24/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to underperform Amgen by 25.2% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date24/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to underperform Regeneron by 13.8% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date24/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Outperforms Mettler-Toledo
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date24/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Lags Edwards Lifesciences
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date24/03/25
    PersonsJeffrey Klein